Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#2861 ×

Actualizaciones regulatorias

3 sept 2026•1 min de lectura

FDA Approves Apotex CILOSTAZOL (ANDA077030)

FDA has approved Apotex's oral cilostazol tablets (50 mg and 100 mg) under ANDA 077030, adding a generic phosphodiesterase‑3 inhibitor to the market.